Zercepac 150 mg
Zercepac 150 mg is a medicine authorised by Swissmedic under authorisation number 67829. The authorisation holder is Accord Healthcare AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 06 July 2021 and the authorisation is valid without a time limit. ATC code L01FD01 places the medicine in the group Antineoplastic agents.
| Authorisation number | 67829 |
|---|---|
| Name | Zercepac 150 mg |
| Full name | Zercepac 150 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Accord Healthcare AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01FD01 |
| First authorisation | 06 July 2021 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Zercepac 150 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung | A | 06 July 2021 |
| 2 | Zercepac 420 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung | A | 06 October 2022 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | L01FD01 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Zercepac 150 mg authorised in Switzerland?
Yes. Zercepac 150 mg is authorised by Swissmedic under authorisation number 67829, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Zercepac 150 mg have?
Zercepac 150 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Zercepac 150 mg?
The authorisation holder is Accord Healthcare AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.